AKT1 and neoplasm: Knockdown of IGF-1 expression level via applying a CRISPR/Cas9 genome editing system could suppress the activation of AKT and Hedgehog signaling pathways, and thereby inhibiting cell proliferation, migration, and tumor aggressiveness in OSCC cells.